Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Pharvaris N.v. buy BiotechBee

Start price
€8.45
21.12.22 / 70%
Target price
€10.00
31.12.24
Performance (%)
32.54%
End price
€11.20
24.06.23
Summary
This prediction ended on 24.06.23 with a price of €11.20. With a performance of 32.54% the BUY prediction by BiotechBee was a big success. BiotechBee has 70% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Pharvaris N.v. - - -
iShares Core DAX® 2.594% -1.861% 13.242%
iShares Nasdaq 100 3.553% -2.064% 38.293%
iShares Nikkei 225® 0.687% -8.704% 17.510%
iShares S&P 500 2.209% -1.988% 27.632%

According to BiotechBee what are the pros and cons of Pharvaris N.v. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Pharvaris N.v. diskutieren
Prediction Buy
Perf. (%) 32.54%
Target price 10.000
Change
Ends at 31.12.24

Buy mit Kursziel 10,0

In the thread Trading Pharvaris N.v.
Prediction Buy
Perf. (%) 32.54%
Target price 10.000
Change
Ends at 31.12.24

Buy beendet

Stopped prediction by BiotechBee for Pharvaris N.v.

buy
Pharvaris N.v.

Start price
Target price
Perf. (%)
€19.60
03.09.23
€26.00
31.12.25
-1.53%
05.09.23

Could be very worthwhile Investment >20% year
buy
Pharvaris N.v.

Start price
Target price
Perf. (%)
€17.80
30.08.23
€25.00
31.12.25
10.11%
03.09.23

Could be very worthwhile Investment >20% year